Long Term Follow up of Water Vapor Thermal Therapy (Rezum) for Benign Prostatic Hyperplasia (BPH)

Helwan University86 enrolled

Overview

This study aims to assess the effectiveness and morbidity of water vapor thermal therapy (Rezūm therapy) for benign prostatic hyperplasia (BPH). Data will be collected and analyzed from patients treated by Rezūm and followed up for 4 years prior to evaluating clinical outcomes.

The investigators will conduct a retrospective study evaluating patients treated with water vapor thermal therapy (Rezūm therapy) for BPH and followed up for4 years. The primary objectives are to assess the long-term effectiveness and morbidity rates associated with the procedure. Data collected will include urinary symptom scores, sexual function, and any treatment-related complications.

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Benign Prostatic Hyperplasia Lower Urinary Track Symptoms

Interventions

water vapor thermal therapy (Rezum) for prostatePROCEDURE

all patients underwent rezum therapy for bph are evaluated for its effectiveness for long period

Eligibility

Sex: MALEMin age: 40 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: * patients underwent rezum procedure for benign prostatic hyperplasia from 2 to 4 years Exclusion Criteria: * previous prostatic intervention * concurrent urological morbidity like urethral stricture * neurological disease like parkinson's disease

Locations (1)

Faculty of Medicine Helwan University

Helwan, Cairo Governorate, Egypt

Outcomes

Primary Outcomes

change in prostate volume

Prostate volume will be measured via transrectal ultrasound.

Time frame: 4 years

hange in International Prostate Symptom Score (IPSS)

IPSS is a questionnaire evaluating urinary symptoms. Scores ranging from 0 to 7 indicate mild symptoms, from 8 to 19 moderate symptoms, and from 20 to 35 severe symptoms.

Time frame: 4 years

international index of erectile function (IIEF)

IIEF is a questionnaire evaluating sexual function. Scores ranging from 5 to 7 indicate severe symptoms, 8 to 11 moderate symptoms, 12 to 16 mild to moderate symptoms, 17 to 21 mild symptoms, and 22 to 25 no erectile dysfunction

Time frame: 4 years

Change in Post-Void Residual Urine

Residual urine volume measured after urination using pelvic ultrasound.

Time frame: 4 years

Secondary Outcomes

Retreatment Rate Following Rezūm Therapy

Number of participants requiring additional treatment for BPH after Rezūm therapy.

Time frame: 4 years

complication rate

incidence of complications post procedure during follow-up

Time frame: 4 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.